Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Novel PET tracers and their future use in assessment of response to treatment

2012 ASCO Annual Meeting

Published: 17 Jun 2012

Views: 4892

Rating:

Save

Dr Andrei Iagaru – Stanford University, CA, USA

Dr Andrei Iagaru talks about the development of novel PET agents at the ASCO 2012 Annual Meeting in Chicago.

The Society of Nuclear Medicine and ASCO organised three sub-sessions on novel imaging methods and the potential new developments in the clinic. The three sub-sessions looked at the basics of PET imaging, PET response criteria and new PET based radiopharmaceuticals.

Agent development is set to continue to get more and more specific and analyse more subsets as time goes on.

Related Videos

Multiple myeloma in a resource constrained setting

Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda

Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )

SABCS 2023: Latest breast cancer diagnostics guidelines

Prof Nadia Harbeck and Prof Giuseppe Curigliano

SABCS 2023: Latest breast cancer diagnostics guidelines ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )

Relapsed Refractory Multiple Myeloma

Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India

$Relapsed Refractory Multiple Myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )$

Hope vs Hype of evidence interpretation

Dr Sanjoy Chatterjee - Tata Medical Center, Kolkata, India

Hope vs Hype of evidence interpretation ( Dr Sanjoy Chatterjee - Tata Medical Center, Kolkata, India )

Choosing Wisely in radiology Tanzania

Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

ASCO GU 2023: Latest updates in mRCC

Dr Javier Puente, Dr Bernard Escudier, Prof Stéphane Oudard, Prof Viktor...

ASCO GU 2023: Latest updates in mRCC ( Dr Javier Puente, Dr Bernard Escudier, Prof Stéphane Oudard, Prof Viktor Grünwald and Prof Toni Choueiri )

Navigating evidence-based care with limited resources in Africa

Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine...

Navigating evidence-based care with limited resources in Africa ( Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine, Accra, Ghana )

Optimum treatment strategy algorithm for mCRC

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Optimum treatment strategy algorithm for mCRC ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

More from ecancer